OPKO Health (OPK) News Today

OPKO Health (NASDAQ:OPK) Shares Gap Down to $1.62

OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Equities research analysts at Zacks Research cut their Q3 2024 earnings estimates for shares of OPKO Health in a note issued to investors on Wednesday, August 28th. Zacks Research analyst R. Department now expects that the biotechnology company will

OPKO Health (NASDAQ:OPK) Trading Up 4.7%

OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) saw some unusual options trading activity on Thursday. Traders bought 4,992 call options on the company. This is an increase of approximately 124% compared to the typical volume of 2,230 call options.

Assenagon Asset Management S.A. cut its stake in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 51.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 614,720 shares of the biotechnology company's stock

OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) major shareholder Opko Health, Inc. sold 59,787 shares of the business's stock in a transaction on Monday, August 12th. The stock was sold at an average price of $33.95, for a total transaction of $2,029,768.65. Following the transaction, the insider now directly owns 2,811,783 shares in the company, valued at approximately $95,460,032.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Large shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.

OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Equities research analysts at Barrington Research cut their Q3 2024 earnings per share (EPS) estimates for OPKO Health in a research report issued to clients and investors on Thursday, August 8th. Barrington Research analyst M. Petusky now forecasts

Vanguard Group Inc. trimmed its position in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 25.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 29,501,231 shares of the biotechnology company's stock after selling 10,250,062 s

OPKO Health (NASDAQ:OPK - Get Free Report) posted its quarterly earnings data on Wednesday. The biotechnology company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.08. The business had revenue of $182.20 million during the quarter, compared to analyst estimates of $184.70 million. OPKO Health had a negative net margin of 31.44% and a negative return on equity of 17.89%. The business's revenue for the quarter was down 31.3% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.03) earnings per share.

Barrington Research raised their price objective on shares of OPKO Health from $1.50 to $2.25 and gave the company an "outperform" rating in a research report on Thursday.

OPKO Health (NASDAQ:OPK) Shares Up 10.2% on Strong Earnings

OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) major shareholder Opko Health, Inc. sold 88,839 shares of the business's stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $33.50, for a total transaction of $2,976,106.50. Following the sale, the insider now directly owns 2,984,564 shares in the company, valued at approximately $99,982,894. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.

OPKO Health (NASDAQ:OPK) will be releasing earnings after the market closes on Wednesday, August 7, Zacks reports.

OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) major shareholder Opko Health, Inc. sold 60,000 shares of the stock in a transaction that occurred on Friday, July 26th. The shares were sold at an average price of $33.85, for a total transaction of $2,031,000.00. Following the transaction, the insider now owns 3,123,403 shares in the company, valued at $105,727,191.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.

OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) major shareholder Opko Health, Inc. sold 25,000 shares of OPKO Health stock in a transaction that occurred on Friday, July 19th. The stock was sold at an average price of $32.29, for a total transaction of $807,250.00. Following the transaction, the insider now owns 3,383,403 shares in the company, valued at $109,250,082.87. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Major shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.

OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) major shareholder Opko Health, Inc. sold 50,000 shares of the firm's stock in a transaction on Monday, July 22nd. The stock was sold at an average price of $32.61, for a total value of $1,630,500.00. Following the transaction, the insider now owns 3,333,403 shares in the company, valued at approximately $108,702,271.83. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Major shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.

OPKO Health (NASDAQ:OPK) Shares Gap Up to $1.42

Piper Sandler dropped their price target on OPKO Health from $5.00 to $3.00 and set an "overweight" rating for the company in a research note on Thursday.